Showing results (381-390 of 441) with videos related to
Sort By:
Pageof 45
Mayo Clinic Proceedings|September 18, 2012
Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular functionJing Li, Andreas J Flammer, Ryan J Lennon, et al.Journal of Hypertension|March 14, 2007
Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertensionAndreas J Flammer, Frank Hermann, Peter Wiesli, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 17, 2013
Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantationYoshiki Matsuo, Andrew Cassar, Satoshi Yoshino, et al.Circulation|April 23, 2008
Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritisAndreas J Flammer, Isabella Sudano, Frank Hermann, et al.European Heart Journal|December 17, 2011
Cardiovascular effects of flavanol-rich chocolate in patients with heart failureAndreas J Flammer, Isabella Sudano, Mathias Wolfrum, et al.International Journal of Cardiology|September 24, 2016
Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndromeM Naegele, A J Flammer, F Enseleit, et al.ESC Heart Failure|July 12, 2020
Differential effect of cardiac resynchronization therapy in patients with diabetes mellitus: a long-term retrospective cohort studyPeter C Kahr, Sander Trenson, Matthias Schindler, et al.International Journal of Cardiology|December 9, 2014
Osteogenic monocytes within the coronary circulation and their association with plaque vulnerability in patients with early atherosclerosisJulia Collin, Mario Gössl, Yoshiki Matsuo, et al.Journal of Geriatric Cardiology : JGC|May 21, 2019
Long-term outcomes after fractional flow reserve-guided percutaneous coronary intervention in patients with severe coronary stenosisYing-Hua Zhang, Jing Li, Andreas J Flammer, et al.European Journal of Heart Failure|October 5, 2023
Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: Data from Swedish Heart Failure RegistryFederica Guidetti, Lars H Lund, Lina Benson, et al.Pageof 45